3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Vesico-Ureteral Reflux
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Signs and Symptoms
1
Prostatic Neoplasms
1
Postoperative Complications
1
Pathologic Processes
1
Pain, Postoperative
1
Pain
1
Neurologic Manifestations
1
Nephrolithiasis
1
Kidney Neoplasms
1
Inflammation
1
Carcinoma, Renal Cell
1
Agnosia
1
Interventions
palbociclib
1
Tea
1
Sufentanil
1
Rivaroxaban
1
Morphine
1
Atorvastatin
1
Analgesia, Patient-Controlled
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Inflammation
×
Morphine
×
Genitourinary
×
Clear all
NCT01367418
2012-03-19
AIMS
Örebro University, Sweden
Phase 3
Completed
26 enrolled